Aug 25, 2026 08:00AM
Jul 7, 2026 07:00AM
Jul 7, 2026 07:00AM
May 15, 2026 07:30AM
Apr 10, 2026 08:39AM
Apr 10, 2026 08:31AM
Apr 10, 2026 08:30AM Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimer's Disease 6-Month NDA Submission
Apr 10, 2026 08:30AM
Apr 8, 2026 09:15AM
Mar 19, 2026 07:31AM
Mar 19, 2026 07:30AM
Mar 19, 2026 07:30AM
Mar 19, 2026 07:30AM
Mar 19, 2026 07:30AM Annovis Partners with NeuroRPM to Deploy AI-Powered Digital Biomarker Technology in Parkinson's Disease Study
Mar 16, 2026 07:30AM
Feb 12, 2026 08:00AM
Feb 12, 2026 08:00AM
Dec 18, 2025 04:35PM
Dec 18, 2025 04:35PM
Dec 18, 2025 04:35PM
Nov 18, 2025 08:45AM Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033
Nov 18, 2025 08:00AM
Nov 18, 2025 08:00AM
Nov 18, 2025 08:00AM
Nov 18, 2025 08:00AM
Sep 30, 2025 07:05AM
Aug 7, 2025 08:00AM
Aug 7, 2025 08:00AM Annovis Completes Full Patent Transfer to Crystal Buntanetap
Jun 5, 2025 08:00AM
Jun 5, 2025 08:00AM
Mar 21, 2025 05:05PM
Feb 5, 2025 08:01AM
Feb 5, 2025 08:00AM
Jan 7, 2025 08:01AM
Jan 7, 2025 08:00AM Annovis Bio Inc. (ANVS) FDA Accepts Final Protocol for Pivotal Phase 3 Alzheimer’s Disease Study, Streamlining Development Pathway
Jan 7, 2025 08:00AM
Jan 7, 2025 08:00AM
Nov 25, 2024 08:00AM
Nov 11, 2024 08:00AM
Oct 31, 2024 08:00AM
Oct 16, 2024 06:56AM
Oct 15, 2024 08:03AM Annovis Bio Inc. (ANVS): FDA Clears Annovis to Launch Pivotal Phase 3 Alzheimer’s Studies, Paving the Way to NDAs
Oct 15, 2024 08:00AM
Oct 2, 2024 08:30AM
Sep 30, 2024 08:05AM
Sep 30, 2024 08:00AM
Sep 3, 2024 07:22AM
Aug 15, 2024 07:00AM
Aug 6, 2024 09:00AM Alzheimer's Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D Activities
Aug 6, 2024 08:30AM

330,652 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All